1. 13‐valent pneumococcal conjugate vaccine (PCV13) is immunogenic and safe in children 6‐17 years of age with sickle cell disease previously vaccinated with 23‐valent pneumococcal polysaccharide vaccine (PPSV23): Results of a phase 3 study. Issue 8 (23rd March 2015) Authors: De Montalembert, Mariane; Abboud, Miguel R.; Fiquet, Anne; Inati, Adlette; Lebensburger, Jeffrey D.; Kaddah, Normeen; Mokhtar, Galila; Piga, Antonio; Halasa, Natasha; Inusa, Baba; Rees, David C.; Heath, Paul T.; Telfer, Paul; Driscoll, Catherine; Al Hajjar, Sami; Tozzi, Alberto; Jiang, Qin; Emini... Journal: Pediatric blood & cancer Issue: Volume 62:Issue 8(2015:Aug.) Page Start: 1427 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 13‐valent pneumococcal conjugate vaccine (PCV13) is immunogenic and safe in children 6‐17 years of age with sickle cell disease previously vaccinated with 23‐valent pneumococcal polysaccharide vaccine (PPSV23): Results of a phase 3 study. Issue 8 (23rd March 2015) Authors: De Montalembert, Mariane; Abboud, Miguel R.; Fiquet, Anne; Inati, Adlette; Lebensburger, Jeffrey D.; Kaddah, Normeen; Mokhtar, Galila; Piga, Antonio; Halasa, Natasha; Inusa, Baba; Rees, David C.; Heath, Paul T.; Telfer, Paul; Driscoll, Catherine; Al Hajjar, Sami; Tozzi, Alberto; Jiang, Qin; Emini... Journal: Pediatric blood & cancer Issue: Volume 62:Issue 8(2015:Aug.) Page Start: 1427 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. A comparison of chronic manual and automated red blood cell exchange transfusion in sickle cell disease patients. (27th January 2015) Authors: Kuo, Kevin H.M.; Ward, Richard; Kaya, Banu; Howard, Jo; Telfer, Paul Journal: British journal of haematology Issue: Volume 170:Number 3(2015:Aug.) Page Start: 425 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. A non-injected opioid analgesia protocol for acute pain crisis in adolescents and adults with sickle cell disease. Issue 2 (April 2022) Authors: Telfer, Paul; Bestwick, Jonathan; Elander, James; Osias, Arlene; Khalid, Nosheen; Skene, Imogen; Nzouakou, Ruben; Challands, Joanne; Barroso, Filipa; Kaya, Banu Journal: British journal of pain Issue: Volume 16:Issue 2(2022) Page Start: 179 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. A patient with β thalassaemia major and back pain. (19th November 2008) Authors: Tsitsikas, Dimitris A; Barroso, Filipa A; Telfer, Paul; Kaya, Banu; Evanson, Jane; Provan, Andrew Journal: BMJ Issue: Volume 337(2008) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Are the risks of treatment to cure a child with severe sickle cell disease too high?. (23rd November 2017) Authors: de Montalembert, Mariane; Brousse, Valentine; Chakravorty, Subarna; Pagliuca, Antonio; Porter, John; Telfer, Paul; Vora, Ajay; Rees, David C Journal: BMJ Issue: Volume 359(2017) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Combination‐therapy with concurrent deferoxamine and deferiprone is effective in treating resistant cardiac iron‐loading in aceruloplasminaemia. (8th April 2015) Authors: Badat, Mohsin; Kaya, Banu; Telfer, Paul Journal: British journal of haematology Issue: Volume 171:Number 3(2015:Nov.) Page Start: 430 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Co‐morbidities and mortality associated with transfusion‐dependent beta‐thalassaemia in patients in England: a 10‐year retrospective cohort analysis. (23rd October 2020) Authors: Jobanputra, Minesh; Paramore, Clark; Laird, Sandra G.; McGahan, Michael; Telfer, Paul Journal: British journal of haematology Issue: Volume 191:Number 5(2020) Page Start: 897 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Deferasirox for iron chelation in multitransfused children with sickle cell disease; long‐term experience in the East London clinical haemoglobinopathy network. (24th September 2014) Authors: Tsouana, Eva; Kaya, Banu; Gadong, Nimze; Hemmaway, Claire; Newell, Heather; Simmons, Andrea; Whitmarsh, Simon; Telfer, Paul Journal: European journal of haematology Issue: Volume 94:Number 4(2015:Apr.) Page Start: 336 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Development and validation of the Satisfaction with Treatment for Pain Questionnaire (STPQ) among patients with sickle cell disease. (23rd June 2019) Authors: Elander, James; Bij, Deepali; Kapadi, Romaana; Schofield, Malcolm B.; Osias, Arlene; Khalid, Nosheen; Kaya, Banu; Telfer, Paul Journal: British journal of haematology Issue: Volume 187:Number 1(2019) Page Start: 105 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗